Related Experiment Videos

In vitro induction and measurement of hemolytic plaque forming cells in man

Insights

Human lymphocytes generate specific hemolytic antibody-producing cells (PFC) in response to antigens. This study introduces a sensitive assay to analyze the cellular interactions crucial for inducing these antibody responses in humans.

Area of Science:

  • Immunology
  • Cell Biology
  • Human Physiology

Background:

  • Human tonsillar lymphocytes are key players in the adaptive immune response.
  • Understanding the induction of antibody-producing cells (PFC) is vital for immune system analysis.

Purpose of the Study:

  • To develop and validate a sensitive assay for enumerating human antibody-producing cells.
  • To analyze the cellular interactions involved in the induction of PFC responses in humans.

Main Methods:

  • Co-cultivation of human tonsillar lymphocytes with sheep red cells or ovalbumin.
  • Enumeration of specific hemolytic plaque-forming cells (PFC) using Microtest-II-plates and poly-L-lysine coupled red cell monolayers.
  • Assessment of plaque formation sensitivity to puromycin and complement.
  • Characterization of PFC using mu-chain and gamma-chain specific antisera.

Main Results:

  • Human lymphocytes generated specific hemolytic PFC peaking at 5-7 days post-induction.
  • Plaque formation was confirmed to be puromycin-sensitive and complement-dependent.
  • PFC exhibited antigen specificity, responding only to the antigen present during culture.
  • Treatment with mu-chain specific antisera inactivated PFC, while gamma-chain antisera had no effect, indicating B-cell origin.

Conclusions:

  • A simple and sensitive assay for human PFC enumeration was successfully developed.
  • The assay allows for the detailed analysis of cellular interactions required for PFC induction.
  • The findings highlight the specificity and regulatory mechanisms of human antibody production.

Related Concept Videos